Charalampos Lazaris

Charalampos Lazaris

Senior Expert I, Oncology Data Science

Novartis Biomedical Research

Biography

Dr. Charalampos Lazaris is a member of the Oncology Data Science team at Novartis Biomedical Research in Cambridge, MA. He explores mechanisms of transcriptional regulation in order to uncover cancer vulnerabilities and target them therapeutically. He earned his Ph.D. at the NYU School of Medicine, under the supervision of Drs. Iannis Aifantis and Aristotelis Tsirigos. During his Ph.D., he focused on genetic alterations of topologically associating domain (TAD) boundaries and their link with aberrant oncogene activation in T-cell acute lymphoblastic leukemia, a type of blood cancer common in children. He completed postdoctoral work at the USC Keck School of Medicine and the Whitehead Institute (MIT). He was also an Associated Scientist at the Klarman Cell Observatory of the Broad Institute of MIT and Harvard. While at Broad Institute, he served as a vice-chair of the NextGen Association. He currently serves as the President of the New York University Graduate School of Arts and Science Doctoral Alumni Association (DAA).

Interests
  • Transcriptional regulation
  • Cancer Epigenetics
  • Cancer Genomics
Education
  • Ph.D. in Systems & Computational Biomedicine, 2018

    New York University (NYU)

  • MS in Systems & Computational Biomedicine, 2016

    New York University (NYU)

  • MS in Bioinformatics, 2012

    University of Edinburgh

  • MS in Molecular Biology-Biomedicine, 2009

    University of Crete

  • MS in Biological Applications and Technologies, 2005

    University of Ioannina

Skills

Technical
Data Science
R
Julia
Nextflow
Python
SQL

Experience

 
 
 
 
 
Novartis
Senior Expert I, Oncology Data Science
May 2024 – Present Cambridge, MA

Responsibilities include:

  • Analysing and integrating epigenomics data to uncover transcriptional dependencies in cancer.
 
 
 
 
 
Novartis
Expert II, Oncology Data Science
May 2022 – May 2024 Cambridge, MA

Responsibilities include:

  • Analysing and integrating epigenomics data to uncover transcriptional dependencies in cancer.
 
 
 
 
 
Broad Institute of MIT and Harvard
Associated Scientist, Klarman Cell Observatory
June 2020 – May 2022 Cambridge, MA
Developed bioinformatics workflows, analysed NGS data, and completed postdoctoral work on transcriptional addiction in multiple myeloma.
 
 
 
 
 
Whitehead Institute
Bioinformatics Scientist
January 2020 – May 2022 Cambridge, MA
Developed bioinformatics workflows, analysed NGS data, and completed postdoctoral work on transcriptional addiction in multiple myeloma.
 
 
 
 
 
University of California, San Diego
Research Associate I
January 2013 – July 2013 La Jolla, CA
Investigated transcriptional response to aging in baker’s yeast.

Accomplish­ments

DataCamp
Julia Fundamentals
See certificate
Coursera
Julia Scientific Programming
See certificate
DataCamp
Python Developer
See certificate
DataCamp
SQL Server Developer
See certificate

Publications

Quickly discover relevant content by filtering publications.
(2022). The dynamic clustering of insulin receptor underlies its signaling and is disrupted in insulin resistance.. Nature Communications.

PDF Cite DOI URL

(2022). Shifting gears: Study of immune system parameters of male habitual marathon runners.. Frontiers in Immunology.

PDF Cite DOI URL

(2021). Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse.. Oncoimmunology.

PDF Cite DOI URL

(2020). Extent and context dependence of pleiotropy revealed by high-throughput single-cell phenotyping.. PLoS Biology.

PDF Cite DOI URL

(2020). Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia.. Nature Genetics.

PDF Cite DOI URL

Contact

  • 250 Massachusetts Ave, Cambridge, MA 02139
  • Enter Building and take the stairs to Office on Floor 3
  • Monday to Friday 9:00 to 17:00
  • Book an appointment
  • DM Me
  • Zoom Me